DBV Technologies CMO sells 464 shares for taxes

DBV Technologies S.A.

Rhea-AI Filing Summary

DBV Technologies S.A. Chief Medical Officer Mohideen Pharis reported a sale of 464 ordinary shares on July 29, 2026 at $2.70 per share. The shares were sold to satisfy withholding tax obligations upon the vesting of restricted stock units. After this transaction, Pharis directly held 144,531 ordinary shares, which may be represented by American Depositary Shares, each currently representing five ordinary shares.

Insider Trade Summary

Net Seller: 464 shares

Net Sell 1 txn

Insider Mohideen Pharis

Role Chief Medical Officer

Sold 464 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F1, F2, F3	464	$2.70	$1K

Holdings After Transaction: Ordinary Shares — 144,531 shares (Direct)

Footnotes (3)

1. F1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
2. F2. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
3. F3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1380 to EURO 1.00 as of July 29, 2026.

Key Figures

Shares sold: 464 ordinary shares Sale price: $2.70 per share Post-transaction holdings: 144,531 ordinary shares +2 more

5 metrics

Shares sold 464 ordinary shares Ordinary shares sold on July 29, 2026 to satisfy tax withholding

Sale price $2.70 per share Price per ordinary share in the July 29, 2026 sale

Post-transaction holdings 144,531 ordinary shares Direct holdings of Mohideen Pharis after the sale

ADS ratio 5 ordinary shares per ADS Each American Depositary Share currently represents five ordinary shares

FX rate $1.1380 to €1.00 Exchange rate used to convert euros to U.S. dollars as of July 29, 2026

Key Terms

American Depositary Shares, restricted stock units, withholding tax obligations, exchange rate

4 terms

American Depositary Shares financial

"may be represented by American Depositary Shares, each currently representing five ordinary shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

restricted stock units financial

"vesting of restricted stock units triggered the tax-related share sale"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

withholding tax obligations financial

"shares sold to satisfy withholding tax obligations upon RSU vesting"

exchange rate financial

"conversion of EURO to USD at an exchange rate of $1.1380 to EURO 1.00"

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider stock transaction did DBVT report for its Chief Medical Officer?

DBV Technologies’ Chief Medical Officer Mohideen Pharis reported selling 464 ordinary shares on July 29, 2026 at $2.70 per share. The sale was made to satisfy withholding tax obligations associated with the vesting of restricted stock units, as described in the footnotes.

Why did DBVT’s Chief Medical Officer sell 464 shares?

The 464 ordinary shares were sold to satisfy withholding tax obligations triggered by the vesting of restricted stock units. This indicates the transaction was related to equity compensation taxation rather than a standalone investment decision, according to the disclosure language.

How many DBVT shares does Mohideen Pharis hold after the reported sale?

Following the transaction, Mohideen Pharis directly held 144,531 ordinary shares of DBV Technologies. These holdings remain after the sale of 464 shares used to cover RSU-related tax withholding obligations on July 29, 2026.

At what price were the DBVT shares sold in this insider transaction?

The reported sale was executed at a price of $2.70 per ordinary share. A footnote also indicates that related U.S. dollar figures reflect conversion from euros using an exchange rate of $1.1380 to €1.00 as of July 29, 2026.

How are DBVT’s ordinary shares represented by American Depositary Shares (ADSs)?

DBV Technologies states that its ordinary shares may be represented by American Depositary Shares. Each ADS currently represents five ordinary shares, which affects how U.S. investors might see the position size when trading ADSs instead of the underlying ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/31/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mohideen Pharis

(Last) (First) (Middle)

C/O DBV TECHNOLOGIES S.A.

107, AVENUE DE LA REPUBLIQUE

(Street)

CHATILLON 92320

(City) (State) (Zip)

FRANCE

(Country)

2. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	07/29/2026		S(2)		464	D	$2.7(3)	144,531	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.

2. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1380 to EURO 1.00 as of July 29, 2026.

	/s/ Virginie Boucinha, Attorney-in-Fact	07/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)